Evercore ISI Boosts Edwards Lifesciences (NYSE:EW) Price Target to $92.00

Edwards Lifesciences (NYSE:EW – Free Report) had its price target upped by Evercore ISI from $86.00 to $92.00 in a research note published on Thursday, Benzinga reports. They currently have an in-line rating on the medical research company’s stock. Several other brokerages also recently weighed in on EW. Morgan Stanley lifted their target price on […]

Related Keywords

United States ,Canada ,Japan ,Catherinem Szyman ,Danielj Lippis ,Edwards Lifesciences ,Gateway Investment Advisers ,Securities Exchange Commission ,Royal Bank ,Edwards Lifesciences Corporation ,Morgan Stanley ,Us Bancorp ,Wells Fargo Company ,Coast Financial ,Edwards Lifesciences Company Profile ,Free Report ,Moderate Buy ,Get Free Report ,Exchange Commission ,Investment Management ,Investment Advisers ,West Coast Financial ,Lifesciences Corporation ,Edwards Lifesciences Daily ,Nyse Ew ,Few ,Medical ,28176e10 ,Boost Price Target ,Evercore Isi ,